Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy
Is a
Allocation Type
Non-Randomized
0
Trial Collaborator
Participating Facility
Health Conditions in Trial
Intervention Model
Single Group Assignment
0
Interventional Trial Phase
Phase 2
0
Interventional Trial Purpose
Treatment
0
Last Updated
January 14, 2009
0
Masking Type
None (Open Label)
0
Primary Completion Date
2007
0
Trial Recruitment Size
38
0
Trial Sponsor
Clinical Trial Start Date
2005
0
Study Completion Date
2007
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase 2 Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy
0
Official Website
Find more entities like Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.